Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Intranasal administration of peptides has been shown effective due to the following factors [27]: Large surface area Permeable endothelial membrane Elimination of first-pass effect Good circulation Researchers who wish to administer the BPC-157 and TB-500 blend via a nasal spray are encouraged to take certain precautions to ensure delivery of maximum bioavailability: To optimize absorption: Wait up to one minute between sprays via the same nostril to prevent oversaturating the nasal membrane and thus losing peptide due to swallowing
That stable energy supports better portion control and pairs well with our appetite support blend, making it easier to overcome cravings
J Diabetes Investig 2023;14:767773.ArticlePubMedPMC 36
| Same drug, different doses | Clinical evidence at each dose | Side effects and tolerability | Practical differences | Cost and access in the UK | Who might benefit from each
Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG (1999) Insulin resistance in patients with cardiac hypertrophy
| doi:10.1007/s10545-007-0666-z Constantin-Teodosiu D, Carlin JI, Cederblad G, Harris RC, Hultman E: Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise (1991) Acta Physiol Scand | doi:10.1111/j.1748-1716.1991.tb09247.x Diamanti K, Cavalli M, Pan G, et al.: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes
